CAR-NK cells in development for treatment of CRC include those that recognize epithelial cell adhesion molecule (EpCAM/CD326), which is overexpressed in many solid tumors and upregulates oncogene expression and cell proliferation [17]. The gene discussed is EPCAM; the disease is colorectal carcinoma.